Filing Details
- Accession Number:
- 0001823239-25-000018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-31 18:20:32
- Reporting Period:
- 2025-01-31
- Accepted Time:
- 2025-01-31 18:20:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1823239 | Maravai Lifesciences Holdings Inc. | MRVI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1832579 | Kurt Oreshack | C/O Maravai Lifesciences Holdings, Inc. 10770 Wateridge Circle, Suite 200 San Diego CA 92121 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2025-01-31 | 25,000 | $5.03 | 167,618 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024.
Billionaire Hedge Funds
